In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate

References

• Snyder RD. Some aspects of the development of methotrexate therapy. Clin Exp Pharmacol Physiol Suppl 1979;5:1–4.
   PubMedGoogle Scholar
• Chabner BA, AllegraCJ, CurtJA, Calabresi P. (1996). Antineoplastic agents. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. ed, Goodman and Gilman’s Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1243–1247.
   Google Scholar
• Lebugle A, Rodrigues A, Bonnevialle P, Voigt JJ, Canal P, Rodriguez F. Study of implantable calcium phosphate systems for the slow release of methotrexate. Biomaterials 2002;23:3517–3522.
   PubMed Web of Science ®Google Scholar
• Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 2009;380:133–141.
   PubMed Web of Science ®Google Scholar
• Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T et al . Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 2005;296:151–161.
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Tumor-targeted liposomes: Doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Control Release 2004;100:135–144.
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138:268–276.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–796.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid–lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. Int J Nanomedicine 2007;2:595–607.
   PubMed Web of Science ®Google Scholar
• Jenning V, Lippacher A, Gohla SH. Medium scale production of solid–lipid nanoparticles (SLN) by high pressure homogenization. J Microencapsul 2002;19:1–10.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid–lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121–128.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid–lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71–77.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid–lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44–56.
   PubMed Web of Science ®Google Scholar
• Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 2008;346:124–132.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid–lipid nanoparticles. Adv Drug Deliv Rev 2007;59:491–504.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, Müller RH, Junyaprasert VB. Influence of oil content on physicochemical properties and skin distribution of nile red-loaded NLC. J Control Release 2008;128:134–141.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of coenzyme Q(10) – development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007;67:141–148.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yue Y, Liu G, Li Y, Zhang J, Yan Z et al. Characterisation and skin distribution of lecithin-based coenzyme q10-loaded lipid nanocapsules. Nanoscale Res Lett 2010;5:1561–1569.
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163–172.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Solid–lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 1999;16:205–213.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2011;22:045101.
   PubMed Web of Science ®Google Scholar
• Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid–lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135–146.
   PubMed Web of Science ®Google Scholar
• Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid–lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 2006;314:56–62.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular anti-angiogenic applications. Int J Pharm 2010;393:167–175.
   PubMed Web of Science ®Google Scholar
• Liu K, Sun J, Wang Y, He Y, Gao K, He Z. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers. Drug Dev Ind Pharm 2008;34:465–471.
   PubMed Web of Science ®Google Scholar
• Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H, Hu FQ. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 2008;361:239–244.
   PubMed Web of Science ®Google Scholar